Synthesis of specifically deuterated saturated and unsaturated phosphatidylserines

A facile chemical synthesis of 1,2-dioleoyl and 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine as well as the synthesis of several deuterated derivatives of phosphatidylserine (2 and 3 positions of serine and in the 3-glycerol position) are described. 360 MHz ¹H NMR spectra of phosphatidylserine and the optical activity of various phosphatidylserine diastereomers were measured.     

β-Ionon und patchoulialkohol aus den unterirdischen teilen von Valeriana officinalis

l-(+)-Bornesitol was detected in 23 of 33 genera of Gentianaceae investigated. The only subtribe without l-(+)-bornesitol (3 species tested) was Exacinae. None of the five genera of Menyanthaceae examined were found to contain l-(+)-bornesitol.     

A novel reaction of S-adenosyl-L-methionine correlated with the activation of pyruvate formate-lyase

Conversion of the inactive form of pyruvate formate-lyase to the catalytically active enzyme is accomplished by the Fe-dependent ‘enzyme II’; reduced flavodoxin, S-adenosyl-L-methionine and the effector pyruvate are required. It was found that adenosylmethionine is reductively processed during activation of pyruvate formate-lyase to yield methionine, adenine and 5-deoxyribose. We suggest that transient adenosylation of enzyme II is required for its function as a converter enzyme.     

Die cucurbitacine in Bryonia alba und Bryonia dioica

The cucurbitacins in roots of Bryonia dioica and B. alba have been investigated. Both species contain the cucurbitacins E, B, I, D, J, K and L, the dihydrocucurbitacins E and B, and tetrahydrocucurbitacin I. The detection of certain cucurbitacin aglycones depends upon the date of harvest, the duration of storage and the methods used for extraction.     

Ultrastructure of the prothoracic gland cells of the last instar of Galleria mellonella in relation to the state of development

The prothoracic glands of the last instar of Galleria mellonella undergo characteristic alterations of their cellular fine structure closely related to cellular activity. During progressive secretory activity of the gland cells there are extensive plasmalemmal infoldings and formation of a pronounced lacunar system. Mitochondria of the active cell phase are characterized by a specific increase in size and paler colour of the matrix. In contrast to the alterations, nuclei, ER and Golgi cisterns do not undergo any submicroscopic changes during the different phases of cellular activity. The relationship between the substructural phenomena and the specific phases of cellular activity are discussed.     

Bacterial surface display library screening by target enzyme labeling: Identification of new human cathepsin G inhibitors

The aim of this study was to establish a new tool for screening surface displayed peptide libraries based on the idea that cells expressing an enzyme inhibitor at the surface can be specifically labeled by the target enzyme. For this purpose peptide P15, exhibiting a K(i) value of 0.25 microM toward human cathepsin G, was expressed on the Escherichia coli cell surface by the use of Autodisplay. Purified cathepsin G was coupled to biotin and incubated with cells expressing the inhibitor. After addition of streptavidin-fluorescein isothiocyanate, these cells could be clearly differentiated from control cells by whole-cell fluorescence using flow cytometer analysis. To determine whether this protocol can be used for the sorting of single cells, a mixed population of cells with and without inhibitor was treated accordingly. Single cells were selected by increased fluorescence and sorted using fluorescence-activated cell sorting (FACS). Single cell clones were obtained and subjected to DNA sequence analysis. It turned out that the bacteria selected by this protocol displayed the correct peptide inhibitor at the cell surface. The protocol was then used to screen random peptide libraries, expressed at the cell surface, and a new lead structure for human cathepsin G (IC50 = 11.7 microM) was identified. The new drug discovery tool presented here consists of three steps: (a) surface display of peptide libraries, (b) selection of single cells with inhibiting structures by using the inherent affinity of the target enzyme, and (c) sorting of single cells, which were labeled by FACS.